New oncology drugs and osteonecrosis of the jaw (ONJ)
Migliorati, C.A.; Covington, J.Stansill.
Journal of the Tennessee Dental Association 89(4) 36-38; Quiz: 38-39
2009
ISSN/ISBN: 0040-3385 PMID: 20102031 Document Number: 629700
Document emailed within 1 workday
Related Documents
Migliorati, C.A.; Covington, J.S. 2009: New oncology drugs and osteonecrosis of the jaw (ONJ) Journal of the Tennessee Dental Association 89(4): 36-38; Quiz: 38-39Niitani, H.; Fukuoka, M.; Furuse, K.; Kudoh, S.; Kurita, Y.; Ohnoshi, T.; Saijoh, N. 1997: New drugs for the treatment of lung cancer. the Tokyo Cooperative Oncology Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(Suppl 1): 117-119
Tonato, M. 2004: Clinical research in oncology: problems and prospects for studying biological drugs I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S3-S4
Warner, J.J.; Philip, J.H.; Brodsky, G.L.; Thornhill, T.S. 1987: Studies of nontraumatic osteonecrosis. The role of core decompression in the treatment of nontraumatic osteonecrosis of the femoral head Clinical Orthopaedics and Related Research 225: 104-127
Medková, J. 1991: Hygienic examination and follow-up of occupational risks of handling cytostatic drugs at an oncology unit Acta Universitatis Palackianae Olomucensis Facultatis Medicae 129: 241-253
Gori, S.; Di Maio, M.; Pinto, C.; Alabiso, O.; Baldini, E.; Beretta, G.Domenico.; Caffo, O.; Caroti, C.; Crinò, L.; De Laurentiis, M.; Dinota, A.; Di Vito, F.; Gebbia, V.; Giustini, L.; Graiff, C.; Guida, M.; Lelli, G.; Lombardo, M.; Muggiano, A.; Puglisi, F.; Romito, S.; Salvagno, L.; Tagliaferri, P.; Terzoli, E.; Venturini, M. 2010: Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM) Tumori 96(6): 1010-1015
Kubal, T.; Peabody, J.W.; Friedman, E.; Levine, R.; Pursell, S.; Letson, D.G. 2015: Using Vignettes to Measure and Encourage Adherence to Clinical Pathways in a Quality-Based Oncology Network: An Early Report on the Moffitt Oncology Network Initiative Managed Care 24(10): 56-64
Lamkin, L.; Rosiak, J.; Buerhaus, P.; Mallory, G.; Williams, M. 2001: Oncology Nursing Society Workforce Survey. Part I: Perceptions of the nursing workforce environment and adequacy of nurse staffing in outpatient and inpatient oncology settings Oncology nursing forum 28(10): 1545-1552
Durand, J.-P.; Goldwasser, F.ço. 2003: New challenges in medical oncology. from medical oncology to oncological medicine Annales de Medecine Interne 154(3): 131-132
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
Goldberg, R.M.; Fleming, T.R.; Tangen, C.M.; Moertel, C.G.; Macdonald, J.S.; Haller, D.G.; Laurie, J.A. 1998: Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group Annals of Internal Medicine 129(1): 27-35
Leichman, L.; Steiger, Z.; Seydel, H.G.; Vaitkevicius, V.K. 1984: Combined preoperative chemotherapy and radiation therapy for cancer of the esophagus: the Wayne State University, Southwest Oncology group and Radiation Therapy Oncology Group experience Seminars in Oncology 11(2): 178-185
McGettigan, P.; Roderick, P.; Mahajan, R.; Kadam, A.; Pollock, A.M. 2015: Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs PLOS Medicine 12(5): E1001826; Discussion E1001826
Lotam, M. 1981: Osteonecrosis Harefuah 100(2): 99-100
Sambrook, P.; Olver, I.; Goss, A. 2006: Bisphosphonates and osteonecrosis of the jaw Australian Family Physician 35(10): 801-803
Blaimont, P.; Maquet, P. 1999: Osteonecrosis of the knee Acta Orthopaedica Belgica 65(Suppl 1): 144-147
Taguchi, A. 2017: Bisphosphonate and osteonecrosis of the jaw Clinical Calcium 27(2): 225-231
Black, K.A.; Khangure, M.S.; Owen, E.T. 1981: Dexamethasone and osteonecrosis Australian and New Zealand Journal of Medicine 11(5): 521-525
Chen, Y.-d. 2011: Case of osteonecrosis Zhongguo Zhen Jiu 31(6): 507
Li, Y.-s.; Wang, S.-l. 2007: Bisphosphonate-associated osteonecrosis Zhonghua Kou Qiang Yi Xue Za Zhi 42(8): 510-512